Fundraising FoxBiolytx
Oklahoma City, US · 1 known investors
Find your way into Biolytx
Sign up to see every warm intro you have to Biolytx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biolytx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
Founders & leadership
HA
H. Anne Pereira, PhDChief Scientific Officer, Co-Founder
WA
William A. HagstromBoard Member, Co-Founder
HA
Heloise Anne PereiraProfessor / Inventor
Investors · 1
In the news
Frequently asked questions
- What does Biolytx do?
- Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
- Who founded Biolytx?
- Biolytx was founded by H. Anne Pereira, PhD, William A. Hagstrom.
- Who are Biolytx's investors?
- Biolytx's investors include Crawley Ventures.
- Where is Biolytx headquartered?
- Biolytx is headquartered in Oklahoma City, US.